Cancer Science

Article	Citations
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes	230
Reactive oxygen species in cancer: Current findings and future directions	210
Tumor microenvironment in gastric cancers	157
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma	139
Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes	128
Pyroptosis, a new bridge to tumor immunity	109
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine	101
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer	90
Circular RNA LPAR3 sponges microRNA‐198 to facilitate esophageal cancer migration, invasion, and metastasis	83
CAR‐NK cell in cancer immunotherapy; A promising frontier	82
Ferroptosis at the crossroads of infection, aging and cancer	81
TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation	79
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer	72
Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors	70
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells	69
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2‐targeting Ab–drug conjugate, in monkeys	66
Ferroptosis‐related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma	63
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma	63
Relationship among DNA double‐strand break (DSB), DSB repair, and transcription prevents genome instability and cancer	62
A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia	59
Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression	59
Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy	57
Functional diversity of cancer‐associated fibroblasts in modulating drug resistance	54
Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer	52
Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma	50

RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma	49
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial	49
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota	47
The roles and regulation of the KLF5 transcription factor in cancers	46
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes	46
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration	45
Tumor‐homing peptide and its utility for advanced cancer medicine	44
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer	44
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab	44
Nuclear microenvironment in cancer: Control through liquid‐liquid phase separation	43
The gut microbiota associated with high‐Gleason prostate cancer	43
Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan	42
RNA‐dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID‐19	42
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single‐arm study	42
Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival	40
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells	39
IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism	39
Clonal hematopoiesis and associated diseases: A review of recent findings	39
Immune infiltration profiling in gastric cancer and their clinical implications	38
Amino acid transporters as emerging therapeutic targets in cancer	38
The noncanonical role of EZH2 in cancer	37
A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway	37
H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA‐519d‐3p/lactate dehydrogenase A axis	37
MiR‐145 in cancer therapy resistance and sensitivity: A comprehensive review	37
The clinical impact of intra‐ and extracellular miRNAs in ovarian cancer	37
Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3	36
Tumor‐associated macrophage interleukin‐β promotes glycerol‐3‐phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells	36
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs	35
Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer	35
Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice	35
Concomitant overexpression of mir‐182‐5p and mir‐182‐3p raises the possibility of IL‐17–producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta‐analysis and experime	35
Potential new therapy of Rapalink‐1, a new generation mammalian target of rapamycin inhibitor, against sunitinib‐resistant renal cell carcinoma	35
Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies	35
Hypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma	34
Long non‐coding RNAs and TGF‐β signaling in cancer	34
Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis	34
Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study	34
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma	34
Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers	34
Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1	33
Personalized cancer vaccination in head and neck cancer	33
PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8+ T cell exhaustion during metastasis	33
Targeting of cancer stem cells by differentiation therapy	33
Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis	33
Establishment and implementation of Cancer Genomic Medicine in Japan	33
A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas	33
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome	32
Long noncoding RNA just proximal to X‐inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A‐dependent manner in gli	32
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study	32
The role of Hippo‐YAP signaling in squamous cell carcinomas	32

Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non‐small‐cell lung cancer patients	31
PTBP1‐targeting microRNAs regulate cancer‐specific energy metabolism through the modulation of PKM1/M2 splicing	31
Gastric cancer–secreted exosomal X26nt increases angiogenesis and vascular permeability by targeting VE‐cadherin	31
Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan	31
A novel scoring method based on RNA‐Seq immunograms describing individual cancer‐immunity interactions	31
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L	31
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine	31
Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients	31
Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer	31
Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles	31
Hypoxia‐inhibited miR‐338‐3p suppresses breast cancer progression by directly targeting ZEB2	31
Extracellular vesicle long non–coding RNA‐mediated crosstalk in the tumor microenvironment: Tiny molecules, huge roles	30
Exosome‐delivered miR‐221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer	30
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling	30
α‐Emitting cancer therapy using 211At‐AAMT targeting LAT1	30
FAM111B enhances proliferation of KRAS‐driven lung adenocarcinoma by degrading p16	29
Prognostic significance of spatial immune profiles in human solid cancers	29
Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma	29
Aldolase A promotes epithelial‐mesenchymal transition to increase malignant potentials of cervical adenocarcinoma	29
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers	28
Tertiary lymphoid structures show infiltration of effective tumor‐resident T cells in gastric cancer	28
Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus	28
Baicalein inhibits non‐small‐cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment	28
Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma	28
A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma	28
Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application	28
Regulation of vascular permeability in cancer metastasis	28
PD‐L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer	28
MiR‐320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling	27
Aptamer‐based biosensors and application in tumor theranostics	27
Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy	27
CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR‐145‐5p and regulating TBX15 expression	27
Multi‐miRNA panel of tumor‐derived extracellular vesicles as promising diagnostic biomarkers of early‐stage breast cancer	27
lncARSR sponges miR‐34a‐5p to promote colorectal cancer invasion and metastasis via hexokinase‐1‐mediated glycolysis	27
Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines	27
CD20+ tumor‐infiltrating immune cells and CD204+ M2 macrophages are associated with prognosis in thymic carcinoma	27
New horizons of DNA adductome for exploring environmental causes of cancer	27
Gastric cancer deaths by age group in Japan: Outlook on preventive measures for elderly adults	27
Role of tumor‐associated macrophages at the invasive front in human colorectal cancer progression	26
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples	26
Serum exosomal microRNA‐766‐3p expression is associated with poor prognosis of esophageal squamous cell carcinoma	26
High expression of Krüppel‐like factor 5 is associated with poor prognosis in patients with colorectal cancer	26
Selective autophagy	26
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab	26
LINC00973 is involved in cancer immune suppression through positive regulation of Siglec‐15 in clear‐cell renal cell carcinoma	26
Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study	26
Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6‐methyladenosine methylation through methyltransferase‐like 14	25
Crossroads of telomere biology and anticancer drug discovery	25
Circulating Epstein‐Barr virus microRNAs BART7‐3p and BART13‐3p as novel biomarkers in nasopharyngeal carcinoma	25
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer	25
OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress	25
Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis	25
MicroRNA‐93 targets WASF3 and functions as a metastasis suppressor in breast cancer	25
CEMIP promotes extracellular matrix‐detached prostate cancer cell survival by inhibiting ferroptosis	25
Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer	25
hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR‐139‐3p/CCL5 axis	24
The BAFF/NFκB axis is crucial to interactions between sorafenib‐resistant HCC cells and cancer‐associated fibroblasts	24
Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review	24
E2F1‐mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10	24
Body mass index and colorectal cancer risk: A Mendelian randomization study	24
Upregulation of adipocyte enhancer‐binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer	24
TET2: A cornerstone in normal and malignant hematopoiesis	24
Mdm2: Open questions	24
Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells	23
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma	23
Retracted: Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression	23
Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer	23
SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors	23
Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis	23
TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer	23
Long noncoding RNA PICSAR/miR‐588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway	23
Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice	23
Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer	22
High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma	22
IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients	22
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma	22
Cancer‐associated mutations in normal human endometrium: Surprise or expected?	22
Proliferation‐associated long noncoding RNA, TMPO‐AS1, is a potential therapeutic target for triple‐negative breast cancer	22
Characteristics of B lymphocyte infiltration in HPV+ head and neck squamous cell carcinoma	22
Tumor‐associated macrophage‐derived transforming growth factor‐β promotes colorectal cancer progression through HIF1‐TRIB3 signaling	22

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma	22
Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers	22
Cancer stem cells and their niche in the progression of squamous cell carcinoma	22
Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin‐mediated interactions	22
Curcumin analog B14 has high bioavailability and enhances the effect of anti‐breast cancer cells in vitro and in vivo	22
A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese	21
Azithromycin enhances the cytotoxicity of DNA‐damaging drugs via lysosomal membrane permeabilization in lung cancer cells	21
Mechanism of tumor‐suppressive cell competition in flies	21
Chaperone‐mediated autophagy receptor modulates tumor growth and chemoresistance in non–small cell lung cancer	21
Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma	21
Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy	21
Nuclear magnetic resonance‐based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis	21
FNDC3B 3′‐UTR shortening escapes from microRNA‐mediated gene repression and promotes nasopharyngeal carcinoma progression	21
Sustained and targeted delivery of siRNA/DP7‐C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy	20
Long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA‐22/Snai	20
Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model	20
Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan	20
Anti‐tumor efficacy of human anti‐c‐met CAR‐T cells against papillary renal cell carcinoma in an orthotopic model	20
Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers	20
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2	20
Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2γ	20
Cell‐to‐cell contact‐mediated regulation of tumor behavior in the tumor microenvironment	20
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer	20
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma	20
Combination of CD47 and signal‐regulatory protein‐α constituting the “don’t eat me signal” is a prognostic factor in diffuse large B‐cell lymphoma	20
Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells	20
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer	20
The heterogeneity of cancer‐associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment	20
Curcumin analog GO‐Y030 boosts the efficacy of anti‐PD‐1 cancer immunotherapy	20
LncRNA BASP1‐AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma	20
Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer	20
Curcumin β‐D‐glucuronide exhibits anti–tumor effects on oxaliplatin‐resistant colon cancer with less toxicity in vivo	20
Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing	19
Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect	19
Nasopharyngeal cancer cell‐derived exosomal PD‐L1 inhibits CD8+ T‐cell activity and promotes immune escape	19
Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma	19
circ_100984‐miR‐432‐3p axis regulated c‐Jun/YBX‐1/β‐catenin feedback loop promotes bladder cancer progression	19
PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction	19
BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma	19
M6A demethylase fat mass and obesity‐associated protein regulates cisplatin resistance of gastric cancer by modulating autophagy activation through ULK1	19
Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas	19
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world	19
The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis	19
Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p	19
Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression	19
LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR‐516b‐5p/Gli1 axis	19
Synergistic effect of ibrutinib and CD19 CAR‐T cells on Raji cells in vivo and in vitro	18
HIF‐1α downregulation of miR‐433‐3p in adipocyte‐derived exosomes contributes to NPC progression via targeting SCD1	18
Nanomedicine targets iron metabolism for cancer therapy	18
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo	18
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial	18
Bromodomain‐containing protein 4 inhibitor JQ1 promotes melanoma cell apoptosis by regulating mitochondrial dynamics	18
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth	18
Collective cancer cell invasion in contact with fibroblasts through integrin‐α5β1/fibronectin interaction in collagen matrix	18
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets	18
ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription	18
Clinical impact of a cancer genomic profiling test using an in‐house comprehensive targeted sequencing system	18
circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR‐423‐5p to activate Wnt5a/Ror2 signaling	18
Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo‐osteogenic balance in bone marrow	18
CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis	18
Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status	18
Current status and future outlook for patient‐derived cancer models from a rare cancer research perspective	18
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF‐β signaling	18
Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B‐cell lymphoma	18
Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer	18
Long‐term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer	18
Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system	18
Tryptophan 2,3‐dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma	18
Safety and efficacy of first‐line dacomitinib in Japanese patients with advanced non‐small cell lung cancer	18
Water‐soluble dietary fiber alleviates cancer‐induced muscle wasting through changes in gut microenvironment in mice	17
Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation	17
Pharmacological targeting of natural killer cells for cancer immunotherapy	17
Single‐cell transcriptome analysis revealed the heterogeneity and microenvironment of gastrointestinal stromal tumors	17
Tumor endothelial cell‐induced CD8+ T‐cell exhaustion via GPNMB in hepatocellular carcinoma	17
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor	17
HS2ST1‐dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior	17
Immunogenic chemotherapy in two mouse colon cancer models	17
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer	17
Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis	17
Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia	17
Preclinical and clinical advances in dual‐target chimeric antigen receptor therapy for hematological malignancies	17
TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma	17
Delta‐like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview	17
Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right‐sided and left‐sided colorectal cancer	17
Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case‐control study	17
Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway	17
Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer	17
Current status of photodynamic technology for urothelial cancer	17
Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728	17
m6A modification–mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability	17
Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model	17
Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid‐like 3B	17
Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer	17
CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor	17
Prognostic impact of CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study	17